Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01369680 · ClinicalTrials.gov registry record · Phase 1

Oral Ketamine for Control of Chronic Pain in Children

A Phase 1 study of Chronic Pain, sponsored by University of Rochester.

Completed
Registry status
Phase 1
Development phase
12
Enrollment target
1
Study location

NCT01369680 is a Phase 1 study of Chronic Pain that has completed, run by University of Rochester. The registered enrollment target is 12 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01369680, a Phase 1 study of Chronic Pain, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
Phase 1
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The study is a maximum tolerated dose finding study for oral, chronic, daily administration of oral ketamine (by mouth) in children with long-term daily pain.

Conditions Studied

Interventions

  • DRUG Ketamine

Study Locations (1)

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2011-05
Est. Completion 2012-10
Phase Phase 1

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT01369680

The ClinicalTrials.gov registry entry for NCT01369680 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (98% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Ketamine is the first listed.

NCT01369680 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01369680 about?

NCT01369680 is a clinical study titled "Oral Ketamine for Control of Chronic Pain in Children". The study is a maximum tolerated dose finding study for oral, chronic, daily administration of oral ketamine (by mouth) in children with long-term daily pain.

What is the current status of trial NCT01369680?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2011-05. Estimated completion is 2012-10.

What conditions does trial NCT01369680 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT01369680?

The interventions under investigation include: Ketamine (DRUG).

Who is sponsoring clinical trial NCT01369680?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01369680 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.